REXAHN PHARMACEUTICALS INC - COM (RNN)

CUSIP: 761640101

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / COM
Total 13F shares
7,050,636
Share change
-486,360
Total reported value
$5,708,000
Price per share
$0.81
Number of holders
29
Value change
-$474,171
Number of buys
12
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 761640101?
CUSIP 761640101 identifies RNN - REXAHN PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REXAHN PHARMACEUTICALS INC - COM (RNN) as of Q3 2014

As of 30 Sep 2014, REXAHN PHARMACEUTICALS INC - COM (RNN) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,050,636 shares. The largest 10 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, AQR CAPITAL MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, CONDOR CAPITAL MANAGEMENT, WELLS FARGO & COMPANY/MN, GOLDMAN SACHS GROUP INC, Northeast Financial Consultants Inc, and Bank of New York Mellon Corp. This page lists 29 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.